Polymorphism of the 3′-untranslated region of interleukin-12 p40 gene is not associated with the presence or severity of coronary artery disease

Circulation Journal

Volumn 69, Issue 7, 2005, Pages 793-797

  Momiyama, Yukihiko ^a   Ohmori, Reiko ^a   Nagano, Makoto ^b   Kato, Ryuichi ^a   Taniguchi, Hiroaki ^a   Egashira, Tohru ^b   Nakamura, Haruo ^c   Ohsuzu, Fumitaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b BML   (Japan)

^c Mitsukoshi Health and Welfare Foundation   (Japan)

Author keywords

Coronary artery disease; Genetics; Interleukin 12; Polymorphism

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; INTERLEUKIN 12; PROTEIN P40; IL12B PROTEIN, HUMAN; INTERLEUKIN 12P40;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CINEANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; CORONARY ARTERY ATHEROSCLEROSIS; GENETICS; HOSPITALIZATION; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CORONARY ARTERIOSCLEROSIS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 22244472655     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.793     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Funayama H, Ishikawa S, Kubo N, Katayama T, Yasu T, Saito M, et al. Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J 2004; 68: 451-454.
3. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
4. Ramshaw AL, Parums DV. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 1990; 17: 543-552.
5. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145: 33-43.
6. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547- 549.
7. Trinchieri G. Interleukin-12: A cytokine produced by antigen-presenting cells with immuno-regulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84: 4008-4027.
8. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97: 2130-2138.
9. Yamashita H, Shimada K, Seki E, Mokubo H, Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris. Am J Cardiol 2003; 91: 133- 136.
10. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, et al. Increased Th1 activity in patients with coronary artery disease. Cytokine 2004; 26: 131-137.
11. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the development of atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 734-742.
12. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003; 163: 1117-1125.
13. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000; 1: 219-224.
14. Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001; 27: 218-221.
15. van Veen T, Crusius JBA, Schrijver HM, Bouma G, Killestein J, van Winsen L, et al. Interleukin-12 p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001; 50: 275-275.
16. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-986.
17. Thom DH, Grayston JT, Siscovick D, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
18. Miya N, Oguchi S, Watanabe I, Kanmatsuse K. Relation of secretory phospholipase A2 and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndrome. Circ J 2004; 68: 628-633.
19. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999; 99: 1161-1164.
20. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. BMJ 2000; 321: 208-212.
21. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F. Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001; 38: 712-717.
22. Lyamichev V, Mast VAL, Hall JG, Prudent JR, Kaiser MW, Takova T, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotides probes. Nat Biotechnol 1999; 17: 292-296.
23. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: High-throughput assay by Invader assay. J Lipid Res 2002; 43: 1011-1018.
24. Nagano M, Yamashita S, Hirano K, Kujiraoka T, Ito M, Sagehashi Y, et al. Point mutation (-69 G-A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. Arterioscler Thromb Vasc Biol 2001; 21: 985-990.
25. Braunwald E. Unstable angina: A classification. Circulation 1989; 80: 410-414.
26. Dahlman I, Eaves IA, Kosoy R, Morrison VA, Heward J, Gough SCL, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002; 30: 149-150.
27. McCormack RM, Maxwell AP, Carson DJ, Patterson CC, Middleton D, Savage DA. The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immun 2002; 3: 433-435.
28. Alloza I, Heggarty S, Goris A, Graham CA, Dubois B, McDonnell G, et al. Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis. Ann Neurol 2002; 52: 524-525.
29. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G. A TaqI polymorphism in the 3′ UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419-423.
30. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Fujita H, et al. Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002; 30: 161-166.
31. Ikeda Y, Tsuzura S, Suehiro T, Yoshida W, Ota K, Osaki F, et al. The polymorphism in the 3′ untranslated region of IL-12B and plasma oxidized LDL concentrations in type 2 diabetic patients (abstract). Atherosclerosis 2003; 2(Suppl): 291.
32. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996; 27: 1555- 1561.
33. Thomas M, Wong Y, Thomas D, Ajaz M, Tsang V, Gallagher PJ, et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 1999; 99: 2733- 2736.
34. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633 - 636.